0000899243-20-033893.txt : 20201215
0000899243-20-033893.hdr.sgml : 20201215
20201215161014
ACCESSION NUMBER: 0000899243-20-033893
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abel Robert Lorne
CENTRAL INDEX KEY: 0001798179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 201389701
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
0
0001490978
Schrodinger, Inc.
SDGR
0001798179
Abel Robert Lorne
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
0
1
0
0
EVP, Science
Common Stock
2020-12-11
4
M
0
14224
3.07
A
40979
D
Common Stock
2020-12-11
4
M
0
1649
2.92
A
42628
D
Common Stock
2020-12-11
4
S
0
200
67.295
D
42428
D
Common Stock
2020-12-11
4
S
0
5200
68.605
D
37228
D
Common Stock
2020-12-11
4
S
0
4300
70.0091
D
32928
D
Common Stock
2020-12-11
4
S
0
1885
70.654
D
31043
D
Common Stock
2020-12-11
4
S
0
4118
72.3105
D
26925
D
Common Stock
2020-12-11
4
S
0
21143
73.3027
D
5782
D
Common Stock
2020-12-11
4
S
0
5782
74.006
D
0
D
Stock Option (right to buy)
3.07
2020-12-11
4
M
0
14224
0.00
D
2026-05-10
Common Stock
14224
0
D
Stock Option (right to buy)
2.92
2020-12-11
4
M
0
1649
0.00
D
2027-06-01
Common Stock
1649
7206
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.15 to $67.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.21 to $69.19, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.30, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.45 to $71.20, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.64 to $72.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.83 to $73.79, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.96 to $74.05, inclusive.
The option was granted on May 11, 2016 and is fully vested.
The option was granted on June 1, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from January 1, 2017 through January 1, 2021.
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel
2020-12-15